High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by The University of New South Wales
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT01733576
First received: November 26, 2012
Last updated: August 11, 2014
Last verified: August 2014
  Purpose

This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.


Condition Intervention Phase
Verbal Learning and Memory
Device: HD-tDCS
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Resource links provided by NLM:


Further study details as provided by The University of New South Wales:

Primary Outcome Measures:
  • Ray Auditory Verbal Learning Test (RAVLT) [ Designated as safety issue: No ]

Estimated Enrollment: 16
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Sham Comparator: Sham HD-tDCS Device: HD-tDCS
Active Comparator: Active HD-tDCS 1 Device: HD-tDCS
Active Comparator: Active HD-tDCS 2 Device: HD-tDCS
Active Comparator: Active HD-tDCS 3 Device: HD-tDCS

  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages 18 - 40 years
  • Right-handed

Exclusion Criteria:

  • concurrent medication likely to affect mental performance
  • current history of drug or alcohol abuse or dependence
  • any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01733576

Contacts
Contact: Donel Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au

Locations
Australia, New South Wales
Black Dog Institute Recruiting
Sydney, New South Wales, Australia, 2031
Contact: Donel Martin, PhD    61 2 9382 9261    donel.martin@unsw.edu.au   
Principal Investigator: Donel Martin, PhD         
Sponsors and Collaborators
The University of New South Wales
  More Information

No publications provided

Responsible Party: Melissa Pigot, Research Assistant, The University of New South Wales
ClinicalTrials.gov Identifier: NCT01733576     History of Changes
Other Study ID Numbers: CB64
Study First Received: November 26, 2012
Last Updated: August 11, 2014
Health Authority: Australia: Therapeutic Goods Administration

ClinicalTrials.gov processed this record on October 19, 2014